tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]carbaMate
- CAS1172623-98-1
- CatalogueRS-U107135
- FormulaC16H19F2NO3
On this page
Product identification
| Product name | tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]carbaMate |
|---|---|
| Catalogue No. | RS-U107135 |
| CAS No. | 1172623-98-1 |
| Molecular formula | C16H19F2NO3 |
| Exact mass | 311.1333 (monoisotopic) |
| InChIKey | OLXPRJZWYJVTID-UONOGXRCSA-N |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Fine Chemicals |
| Drug substance | Omarigliptin |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-U107135 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Omarigliptin
- Fine Chemicals of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-U107135
- Request a quotation for RS-U107135
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Omarigliptin
All 22 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Omarigliptin
IN STOCKRS-U018023(2S,3R,5S)-Omarigliptin
CUSTOM SYNTHESISRS-U0094282,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole
CUSTOM SYNTHESISRS-Z401K32Desmethylsulfonyl-Omarigliptin
IN STOCKRS-Z401MHPOmarigliptin Impurity
BACK ORDERRS-O124004tert-Butyl 1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-5-carboxylate
IN STOCKRS-I516067tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate
IN STOCKRS-Z396SGROmarigliptin Impurity 1
IN STOCKRS-I001A7XOmarigliptin Impurity 4
BACK ORDERRS-I001205Omarigliptin Impurity 4
CUSTOM SYNTHESISRS-O124001Omarigliptin Impurity 5
IN STOCKRS-O124003Omarigliptin Impurity 6
CUSTOM SYNTHESISRS-O124002Omarigliptin Impurity 7
IN STOCKRS-O124007Omarigliptin Impurity 8
IN STOCKRS-O124005Omarigliptin Impurity 12
BACK ORDERRS-U096493Omarigliptin Impurity 15
IN STOCKRS-O124006Omarigliptin Impurity 16
IN STOCKRS-U005041Omarigliptin Impurity 17
IN STOCKRS-O124008Omarigliptin Impurity 19
IN STOCKRS-O124009Omarigliptin Impurity 21
CUSTOM SYNTHESISRS-O124010
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.


![Chemical structure of 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole](/structures/w4/QMYMFLBEKDKSOX-UHFFFAOYSA-N.webp?v=11)


![Chemical structure of tert-Butyl 1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-5-carboxylate](/structures/w4/NMISNVXMWMBRGM-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of tert-Butyl 2-(Methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate](/structures/w4/SNEHALFDVXIDSZ-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate](/structures/w4/IBUNCTVDGYIKAP-UHFFFAOYSA-N.webp?v=11)











